Bioten Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2022	FY 2021
Period Ending	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	1,023	167.16
Depreciation & Amortization	107.88	111.99
Loss (Gain) From Sale of Assets	-1.81	-
Asset Writedown & Restructuring Costs	229.28	-
Loss (Gain) From Sale of Investments	4.1	-
Provision & Write-off of Bad Debts	8.17	17.2
Other Operating Activities	298.39	100.62
Change in Accounts Receivable	119.97	-888.53
Change in Inventory	225.44	127.37
Change in Accounts Payable	-44.05	1,255
Change in Other Net Operating Assets	209.51	143.03
Operating Cash Flow	2,180	1,034
Operating Cash Flow Growth	110.88%	-
Capital Expenditures	-100.6	-
Sale of Property, Plant & Equipment	24.21	-
Sale (Purchase) of Intangibles	-20	-
Investment in Securities	-11.74	-12.03
Other Investing Activities	-41.99	-14.62
Investing Cash Flow	-150.11	-26.65
Short-Term Debt Issued	270	100
Long-Term Debt Issued	-	198.33
Total Debt Issued	270	298.33
Short-Term Debt Repaid	-40	-300
Long-Term Debt Repaid	-813.33	-490.5
Total Debt Repaid	-853.33	-790.5
Net Debt Issued (Repaid)	-583.33	-492.17
Other Financing Activities	-	-2.19
Financing Cash Flow	-583.33	-494.36
Miscellaneous Cash Flow Adjustments	-0	-0
Net Cash Flow	1,447	512.92
Free Cash Flow	2,080	1,034
Free Cash Flow Growth	101.15%	-
Free Cash Flow Margin	19.43%	17.04%
Free Cash Flow Per Share	668.55	364.94
Levered Free Cash Flow	1,611	-
Unlevered Free Cash Flow	1,679	-
Change in Working Capital	510.87	636.96

Source: S&P Global Market Intelligence. Standard template. Financial Sources.